<?xml version="1.0" encoding="UTF-8"?>
<p id="p0120">THC demonstrated potential pharmacological actions against obesity and non-alcoholic fatty liver diseases [
 <xref rid="bib77" ref-type="bibr">77</xref>, 
 <xref rid="bib78" ref-type="bibr">78</xref>]. It could suppress oleic acid-induced steatosis in hepatocellular carcinoma cells by modulating several targets like Sterol regulatory element-binding protein 1, Peroxisome proliferator-activated receptor gamma, Fatty acid synthase andFatty acid-binding protein-4 [
 <xref rid="bib77" ref-type="bibr">77</xref>].
</p>
